Belgian VMD acquires Laboratoires Biové
Veterinary medicine manufacturer VMD, based in
Arendonk, Belgium, has announced that it has acquired the private French
pharmaceutical laboratory Laboratoires Biové.
Biové's offices are located in Arques, the North of France with a strong
market presence in other areas of the world including Magreb, the Middle East
and South East Asia.
Jan Moons (managing director and CEO of VMD) will be the majority shareholder
of the new entity with Pierre Stoven (managing director of Biové) retaining a
minority stake in the new structure. The board of directors of both companies
will be actively involved in the overall management process.
companies will expand independently on a national basis whilst competently
continuing to serve all major and existing partnerships," explained Moons.
"The company structures will remain unchanged: internationally, VMD
will focus more on enhancing sales & marketing as well as research and
development whereas Biové will focus on the production process. Biové will also
coordinate all toll manufacturing opportunities directly with their existing
The company provides a wide range of registered antibiotics, vitamins and
chemotherapeutics in the form of injectable preparations, water soluble powders
and premixes relating to the treatment of animal diseases that mainly affect
VMD, privately owned, is market leader in its field
in Belgium. Its veterinary medicines are currently marketed in more than 70
other countries worldwide through a network of distributors and VMD subsidiaries
in Hungary, Turkey and Nigeria.
The pharmaceutical laboratory
Laboratoires Biové produces its own product range in France, mainly for
productive livestock, i.e.
livestock intended for
human consumption (for example, bovines, poultry, fish and bees) as well as
dedicated formulations for pets.
For the latest pig news, subscribe
To comment, login here
Or register to be able to comment.